Michela Pierini

Via Pupilli, 1
Bologna, 40136, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Integrated Immune and Molecular Profiling Identifies Prognostic Subgroups and Therapeutic Targets in Chondrosarcoma.

Integrated Immune and Molecular Profiling Identifies Prognostic Subgroups and Therapeutic Targets in Chondrosarcoma.

Journal: International journal of molecular sciences

Published: January 18, 2026

Psychosocial impact of COVID-19 pandemic on patients with solid malignancies and bone metastases (PsyCO-B): a multicentre prospective observational study.

Psychosocial impact of COVID-19 pandemic on patients with solid malignancies and bone metastases (PsyCO-B): a multicentre prospective observational study.

Journal: Journal of bone oncology

Published: November 23, 2025

Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials.

Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 18, 2025

A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl).

A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl).

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 19, 2022

Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative Study.

Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative Study.

Journal: Cancers

Published: April 19, 2022

Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial.

Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial.

Journal: Cancer immunology, immunotherapy : CII

Published: October 19, 2020

High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series.

High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series.

Journal: Cells

Published: September 22, 2020

Is there a role for chemotherapy after local relapse in high-grade osteosarcoma?

Is there a role for chemotherapy after local relapse in high-grade osteosarcoma?

Journal: Pediatric blood & cancer

Published: December 29, 2018

Denosumab in patients with aneurysmal bone cysts: A case series with preliminary results.

Denosumab in patients with aneurysmal bone cysts: A case series with preliminary results.

Journal: Tumori

Published: August 09, 2018

Circulating Candidate Biomarkers in Giant Cell Tumors of Bone.

Circulating Candidate Biomarkers in Giant Cell Tumors of Bone.

Journal: Proteomics. Clinical applications

Published: February 01, 2018

Fabrication of Innovative Silk/Alginate Microcarriers for Mesenchymal Stem Cell Delivery and Tissue Regeneration.

Fabrication of Innovative Silk/Alginate Microcarriers for Mesenchymal Stem Cell Delivery and Tissue Regeneration.

Journal: International journal of molecular sciences

Published: July 18, 2017

Complexity in internal medicine wards: A novel screening method and implications for management.

Complexity in internal medicine wards: A novel screening method and implications for management.

Journal: Journal of evaluation in clinical practice

Published: June 27, 2017

Showing 1-12 of 19

Last Updated: 09/26/2026